Item 5.07. Submission of Matters to a Vote of Securityholders.
On May 13, 2020, in connection with that certain Agreement and Plan of Merger,
dated May 11, 2020, by and among TearLab Corporation (the "Company"), Accelmed
Partners II LP and Accelmed Merger Sub, Inc., certain of the stockholders of the
Company executed and delivered a written consent (the "Written Consent")
contemplating the adoption and approval of the Merger Agreement and the
transactions contemplated thereby on behalf of the stockholders of the Company.
The Written Consent will become effective on the applicable record date, which
is May 18, 2020. Thereafter, no further approval of the stockholders of the
Company is required to effectuate the transactions contemplated by the Merger
Agreement.
The Company will prepare an information statement for its stockholders
containing the information with respect to the Merger Agreement, the
transactions contemplated thereby and the Written Consent, as required by
Schedule 14C promulgated under the Securities Exchange Act of 1934, as amended.
When completed, the definitive information statement will be mailed to the
Company's stockholders.
© Edgar Online, source Glimpses
TEARLAB CORPORATION 
